2 months Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $35.00 MarketBeat
Evercore ISI increased their price target on Kiniksa Pharmaceuticals from $30.00 to $35.00 and gave the stock an “outperform” rating in a research report on Wednesday.
Nasdaq 100 · Pharmaceuticals · Science
X